Ground Swell Capital’s Tenaya Therapeutics TNYA Stock Holding History

Ground Swell Capital’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,262	Closed	-$31.8K	–	257
2024 Q4	$31.8K	Buy	+22,262	New	+$49.9K	0.05%	102

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's TNYA Position: Q1 2025 in Review

Ground Swell Capital sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 22,262 shares — an estimated $31.8K sold.

Ground Swell Capital first reported a position in TNYA in Q4 2024 and held it in 1 quarter. The position peaked at $31.8K in Q4 2024. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

Ground Swell Capital reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
Ground Swell Capital sold 22,262 Tenaya Therapeutics shares in Q1 2025, an estimated $31.8K.
Ground Swell Capital first reported a position in Tenaya Therapeutics in Q4 2024 and held it in 1 quarter.
Ground Swell Capital's Tenaya Therapeutics position peaked at $31.8K in Q4 2024.
107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.